CPhI Worldwide – organized by UBM (part of Informa PLC) – has announced the opening of the 2018 CPhI Pharma Awards for entries. The industry’s preeminent awards return for a landmark 15th edition, with 17 categories honouring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies. This year's categories include: â Excellence in Pharma: CEO of the Year â Excellence in Pharma: Supply Chain, Logistics, and Distribution â Excellence in Pharma: Contract Services and Outsourcing â Excellence in Pharma: Regulatory Procedures and Compliance â Excellence in Pharma: Corporate Social Responsibility â Excellence in Pharma: Pharma Company of the Year â Excellence in Pharma: OTC â Excellence in Pharma: Patient Centricity â Excellence in Pharma: IT, mHealth & Digitalisation Last year, the awards received a record number of submissions (over 200 applications). CPhI Worldwide is expecting greater interest in 2018. Former winners of the CEO of the year award include Vivek Sharma, CEO of Piramal (winner in 2015); Udit Batra, CEO of Merck (winner in 2016), and last year Richard Chin, MD, founder and CEO of Kindred Biosciences. Another increasingly significant category is the Corporate Social Responsibility award, which will be given in partnership with official charity partner, International Medical Corps. Orhan Caglayan, Brand Director – CPhI Worldwide, UBM (part of Informa PLC), commented: “The awards are now rightly lauded as the most prestigious in pharma. If you or your company want to be recognized amongst the industry and your peers as driving forward developments, we encourage you to take part – all pharma and supply chain companies are welcome.” Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31, 2018 – with shortlisted finalists announced August 28, 2018. The winners will be unveiled during a ceremony at the prestigious Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide. To apply please visit https://awards.cphi.com
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
February 7th 2025Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.